feed,title,long_url,short_url
Benzinga,Spero Therapeutics' Shares Plunge As FDA Issued Refusal Letter For Urinary Tract Infection Candidate,https://benzinga.com/general/biotech/22/06/27871445/spero-therapeutics-shares-plunge-as-fda-issued-refusal-letter-for-urinary-tract-infection-candida,https://bit.ly/3QRa3Gj
